NGM BIOPHARMACEUTICALS INC Increase (Decrease) in Contract with Customer, Liability
NGM BIOPHARMACEUTICALS INC reported Increase (Decrease) in Contract with Customer, Liability of -$366.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2024-03-11
- NGM BIOPHARMACEUTICALS INC increase (decrease) in contract with customer, liability for the quarter ending 2023-12-31 was -$107.00K.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in contract with customer, liability for the quarter ending 2023-09-30 was -$582.00K, a 223.83% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in contract with customer, liability for the quarter ending 2023-06-30 was $313.00K, a 77.32% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in contract with customer, liability for the quarter ending 2023-03-31 was $10.00K.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in contract with customer, liability for fiscal 2023 was -$366.00K.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in contract with customer, liability for fiscal 2022 was -$17.41M, a 197.94% decline from fiscal 2021.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in contract with customer, liability for fiscal 2021 was $17.77M.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in contract with customer, liability for fiscal 2020 was -$4.87M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$689.00K derived: sum of 2 quarters · filed 2024-03-11 | -$376.00K derived: sum of 3 quarters · filed 2024-03-11 | -$366.00K 10-K · filed 2024-03-11 |
| 2023-09-30 | -$582.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$269.00K derived: sum of 2 quarters · filed 2023-11-02 | -$259.00K 10-Q · filed 2023-11-02 | -$6.86M derived: sum of 4 quarters · filed 2024-03-11 |
| 2023-06-30 | $313.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $323.00K 10-Q · filed 2023-08-03 | -$6.28M derived: sum of 3 quarters · filed 2024-03-11 | -$5.81M derived: sum of 4 quarters · filed 2024-03-11 |
| 2023-03-31 | $10.00K 10-Q · filed 2023-05-04 | -$6.59M derived: sum of 2 quarters · filed 2024-03-11 | -$6.12M derived: sum of 3 quarters · filed 2024-03-11 | -$4.74M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-12-31 | -$6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$6.13M derived: sum of 2 quarters · filed 2024-03-11 | -$4.75M derived: sum of 3 quarters · filed 2024-03-11 | -$17.41M 10-K · filed 2024-03-11 |
| 2022-09-30 | $470.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.85M derived: sum of 2 quarters · filed 2023-11-02 | -$10.81M 10-Q · filed 2023-11-02 | -$5.32M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$11.28M 10-Q · filed 2023-08-03 | -$5.79M derived: sum of 3 quarters · filed 2024-03-11 | $1.53M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | -$12.66M 10-Q · filed 2023-05-04 | -$7.17M derived: sum of 2 quarters · filed 2024-03-11 | $154.00K derived: sum of 3 quarters · filed 2024-03-11 | $5.12M derived: sum of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | $5.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $12.81M derived: sum of 2 quarters · filed 2024-03-11 | $17.77M derived: sum of 3 quarters · filed 2024-03-11 | $17.77M 10-K · filed 2024-03-11 |
| 2021-09-30 | $7.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $12.29M derived: sum of 2 quarters · filed 2022-11-03 | $12.29M 10-Q · filed 2022-11-03 | $7.70M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $4.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.96M 10-Q · filed 2022-08-04 | $377.00K derived: sum of 3 quarters · filed 2023-02-28 | $2.89M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | -$4.59M derived: sum of 2 quarters · filed 2023-02-28 | -$2.07M derived: sum of 3 quarters · filed 2023-02-28 | $0.00 derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$2.07M derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | -$4.87M 10-K · filed 2023-02-28 |
| 2020-09-30 | $2.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $4.59M derived: sum of 2 quarters · filed 2021-11-04 | -$286.00K 10-Q · filed 2021-11-04 | -$10.04M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$2.80M 10-Q · filed 2021-08-05 | -$12.55M derived: sum of 3 quarters · filed 2022-03-01 | -$15.37M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$4.87M 10-Q · filed 2021-05-06 | -$14.62M derived: sum of 2 quarters · filed 2022-03-01 | -$17.44M derived: sum of 3 quarters · filed 2022-03-01 | -$22.04M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$9.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$12.57M derived: sum of 2 quarters · filed 2022-03-01 | -$17.17M derived: sum of 3 quarters · filed 2022-03-01 | -$24.25M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$7.42M derived: sum of 2 quarters · filed 2020-11-12 | -$14.50M 10-Q · filed 2020-11-12 | -$21.83M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-06-30 | -$4.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$11.68M 10-Q · filed 2020-08-12 | -$19.02M derived: sum of 3 quarters · filed 2021-03-15 | -$22.88M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-03-31 | -$7.08M 10-Q · filed 2020-05-13 | -$14.42M derived: sum of 2 quarters · filed 2021-03-15 | -$18.28M derived: sum of 3 quarters · filed 2021-03-15 | -$26.59M derived: sum of 4 quarters · filed 2021-03-15 |
| 2018-12-31 | -$7.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$11.19M derived: sum of 2 quarters · filed 2021-03-15 | -$19.51M derived: sum of 3 quarters · filed 2021-03-15 | -$21.13M 10-K · filed 2021-03-15 |
| 2018-09-30 | -$3.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$12.18M derived: sum of 2 quarters · filed 2019-11-12 | -$13.80M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$8.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$9.94M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | -$1.62M 10-Q · filed 2019-05-16 | |||
| 2017-12-31 | -$16.52M 10-K · filed 2020-03-17 |